Literature DB >> 19484454

Humphrey perimetry as a predictor of visual improvement after photodynamic therapy.

Mitsuhiro Imasawa, Toyoaki Tsumura, Toyohiko Kikuchi, Arata Sekine, Hiroyuki Iijima.   

Abstract

Mesh:

Substances:

Year:  2009        PMID: 19484454     DOI: 10.1007/s10384-008-0644-5

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


× No keyword cloud information.
  4 in total

1.  Angiographic lesion of polypoidal choroidal vasculopathy on indocyanine green and fluorescein angiography.

Authors:  Fumi Gomi; Miki Sawa; Keiichi Mitarai; Motokazu Tsujikawa; Yasuo Tano
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-03-09       Impact factor: 3.117

2.  Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.

Authors: 
Journal:  Arch Ophthalmol       Date:  1999-10

3.  Effect of lesion size, visual acuity, and lesion composition on visual acuity change with and without verteporfin therapy for choroidal neovascularization secondary to age-related macular degeneration: TAP and VIP report no. 1.

Authors:  Keven J Blinder; Shannon Bradley; Neil M Bressler; Susan B Bressler; Guy Donati; Yong Hao; Colin Ma; Ugo Menchini; Joan Miller; Michael J Potter; Constantin Pournaras; Al Reaves; Philip J Rosenfeld; H Andrew Strong; Michael Stur; Xiang Yao Su; Gianni Virgili
Journal:  Am J Ophthalmol       Date:  2003-09       Impact factor: 5.258

Review 4.  Management of neovascular age-related macular degeneration.

Authors:  Ursula M Schmidt-Erfurth; Christian Pruente
Journal:  Prog Retin Eye Res       Date:  2007-03-27       Impact factor: 21.198

  4 in total
  1 in total

1.  Photodynamic therapy for polypoidal choroidal vasculopathy: baseline perimetric results and visual outcomes.

Authors:  Mitsuhiro Imasawa; Toyoaki Tsumura; Arata Sekine; Toyohiko Kikuchi; Hiroyuki Iijima
Journal:  Jpn J Ophthalmol       Date:  2009-12-18       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.